YORVIPATH® (palopegteriparatide) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of chronic hypoparathyroidism in adults1

Clinicians can now access evidence-based clinical content live during consultations via the Corti Assistant app

MUNICH,Feb. 19,2025--On February 17,2025,GCL System Integration (GCL SI) achieved a significant milestone by securing the EcoVadis Group-level Silver Medal certification. In its first attempt,GCL SI s

The next generation of textile printing ink reshaping the global textile dyeing industry Enables DTP printing without fabric pre- and post-processing,reducing time and costs

Acquisition expands LexisNexis Risk Solutions\' capabilities in risk and fraud solutions and enhances digital identity onboarding and identity verification through AI-powered technology

NEWARK,Del. and NANJING,China,Feb. 19,2025-- Biosion,Inc. ("Biosion"),a global clinical-stage biotechnology company,is pleased to announce the appointment of Kedan Lin,Ph.D.,as Chief Develop